Quantum Dot Targets Midrange Gene-Expression Studies

Courtesy of Quantum DoWhen it comes to gene-expression analysis, researchers seem always to be sacrificing something. With real-time quantitative PCR, it's gene number: Though inexpensive enough to apply to large numbers of samples, each assay can test, at best, three or four transcripts simultaneously. Microarrays, on the other hand, sacrifice sample throughput, probing tens of thousands of genes in a single sample.Quantum Dot http://www.qdots.com has developed a compromise solution. According

Written byJeffrey Perkel
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Courtesy of Quantum Do

When it comes to gene-expression analysis, researchers seem always to be sacrificing something. With real-time quantitative PCR, it's gene number: Though inexpensive enough to apply to large numbers of samples, each assay can test, at best, three or four transcripts simultaneously. Microarrays, on the other hand, sacrifice sample throughput, probing tens of thousands of genes in a single sample.

Quantum Dot http://www.qdots.com has developed a compromise solution. According to Andy Watson, vice president of business development for the Hayward, Calif.-based nanotech company, the Mosaic™ Gene Expression Analysis System enables users to assess expression of 200 or so genes across 384 samples.

Key to the Mosaic system is a set of addressable magnetic spheres called Qbead™ microspheres. Each Qbead is coated with a precise blend of quantum dots that gives the bead a unique color; this identifies the bead and by extension, the assay being performed on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies